The U.S. Food and Drug Administration is seeking to strengthen the warning labels on popular painkillers – NSAIDs, non-aspirin nonsteroidal anti-inflammatory drugs. NSAIDs are typically used to relieve pain and fever, and can come in high dose prescriptions or low dose over-the-counter options. The FDA is calling upon drugmakers to upgrade warning labels to highlight increased risk of stroke and heart attack that can accompany misuse of the drugs. Thus far, most drug manufacturers are referencing clinical studies that explain very little risk when taken as directed. However, Pfizer and Bayer both explain they will work with the FDA to incorporate the necessary labeling.

Click here to read the full article by Debra Goldschmidt for CNN.